Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Pérez de Diego, Ana Cristina ^b   Athmaram, Thimmasandra N ^a   Stewart, Meredith ^a   Rodríguez Sánchez, Belén ^b   Sánchez Vizcaíno, José Manuel ^b   Noad, Robert ^a,c   Roy, Polly ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS LIKE PARTICLE VACCINE; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; APATHY; ARTICLE; BLUETONGUE; BLUETONGUE ORBIVIRUS; BONE SWELLING; CAUSE OF DEATH; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DYSPNEA; FEVER; HYPERSALIVATION; IMMUNE RESPONSE; IMMUNOLOGICAL MONITORING; IMMUNOREACTIVITY; INFECTION PREVENTION; MALE; NONHUMAN; PROVOCATION TEST; SEROTYPE; SHEEP; TREATMENT DURATION; VACCINE PRODUCTION; VIREMIA; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; SHEEP; TREATMENT OUTCOME; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE;

ANIMALIA; ARTHROPODA; BLUETONGUE VIRUS; BOS; OVIS ARIES;

EID: 80054845228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026666     Document Type: Article

References (33)

1. Roy P, Noad R, (2006) Bluetongue virus assembly and morphogenesis. Curr Top Microbiol Immunol 309: 87-116.
2. Maclachlan NJ, Drew CP, Darpel KE, Worwa G, (2009) The pathology and pathogenesis of bluetongue. J Comp Pathol 141: 1-16.
3. Schwartz-Cornil I, Mertens PP, Contreras V, Hemati B, Pascale F, et al. (2008) Bluetongue virus: virology, pathogenesis and immunity. Vet Res 39: 46.
4. MacLachlan NJ, Crafford JE, Vernau W, Gardner IA, Goddard A, et al. (2008) Experimental reproduction of severe bluetongue in sheep. Vet Pathol 45: 310-315.
5. Chaignat V, Worwa G, Scherrer N, Hilbe M, Ehrensperger F, et al. (2009) Toggenburg Orbivirus, a new bluetongue virus: initial detection, first observations in field and experimental infection of goats and sheep. Vet Microbiol 138: 11-19.
6. Hofmann MA, Renzullo S, Mader M, Chaignat V, Worwa G, et al. (2008) Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland. Emerg Infect Dis 14: 1855-1861.
7. Maan S, Maan NS, Nomikou K, Batten C, Antony F, et al. (2011) Novel bluetongue virus serotype from Kuwait. Emerg Infect Dis 17: 886-889.
8. Purse BV, Brown HE, Harrup L, Mertens PP, Rogers DJ, (2008) Invasion of bluetongue and other orbivirus infections into Europe: the role of biological and climatic processes. Rev Sci Tech 27: 427-442.
9. Mellor PS, Carpenter S, Harrup L, Baylis M, Mertens PP, (2008) Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006. Prev Vet Med 87: 4-20.
10. Savini G, MacLachlan NJ, Sanchez-Vizcaino JM, Zientara S, (2008) Vaccines against bluetongue in Europe. Comp Immunol Microbiol Infect Dis 31: 101-120.
11. Roy P, Boyce M, Noad R, (2009) Prospects for improved bluetongue vaccines. Nat Rev Microbiol 7: 120-128.
12. Velthuis AG, Mourits MC, Saatkamp HW, de Koeijer AA, Elbers AR, (2011) Financial evaluation of different vaccination strategies for controlling the bluetongue virus serotype 8 epidemic in the Netherlands in 2008. PLoS One 6: e19612.
13. Velthuis AG, Saatkamp HW, Mourits MC, de Koeijer AA, Elbers AR, (2010) Financial consequences of the Dutch bluetongue serotype 8 epidemics of 2006 and 2007. Prev Vet Med 93: 294-304.
14. Noad R, Roy P, (2009) Bluetongue vaccines. Vaccine 27 (Suppl 4): D86-89.
15. Noad R, Roy P, (2003) Virus-like particles as immunogens. Trends Microbiol 11: 438-444.
16. Roy P, Noad R, (2009) Virus-like particles as a vaccine delivery system: myths and facts. Adv Exp Med Biol 655: 145-158.
17. Rodriguez-Sanchez B, Iglesias-Martin I, Martinez-Aviles M, Sanchez-Vizcaino JM, (2008) Orbiviruses in the Mediterranean basin: updated epidemiological situation of Bluetongue and new methods for the detection of BTV serotype 4. Transbound Emerg Dis 55: 205-214.
18. Huismans H, Erasmus BJ, (1981) Identification of the serotype-specific and group-specific antigens of bluetongue virus. Onderstepoort J Vet Res 48: 51-58.
19. Savini G, Hamers C, Conte A, Migliaccio P, Bonfini B, et al. (2009) Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet Microbiol 133: 1-8.
20. Roy P, Bishop DH, LeBlois H, Erasmus BJ, (1994) Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12: 805-811.
21. Stewart M, Bhatia Y, Athmaran TN, Noad R, Gastaldi C, et al. (2010) Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. Vaccine 28: 3047-3054.
22. Noad RJ, Stewart M, Boyce M, Celma CC, Willison KR, et al. (2009) Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA. BMC Mol Biol 10: 87.
23. Wackerlin R, Eschbaumer M, Konig P, Hoffmann B, Beer M, (2010) Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle. Vaccine 28: 4348-4355.
24. Oura CA, Wood JL, Sanders AJ, Bin-Tarif A, Henstock M, et al. (2009) Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine 27: 7326-7330.
25. Erasmus BJ, (1990) Bluetongue. In: Dinter Z, Morein B, editors. Virus Infections of Ruminants Amsterdam, The Netherlands Elsevier Science Publishers B. V.
26. Umeshappa CS, Singh KP, Channappanavar R, Sharma K, Nanjundappa RH, et al. (2011) A comparison of intradermal and intravenous inoculation of bluetongue virus serotype 23 in sheep for clinico-pathology, and viral and immune responses. Vet Immunol Immunopathol 141: 230-238.
27. Stewart M, Bhatia Y, Athmaran TN, Noad R, Gastaldi C, et al. (2009) Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. Vaccine 28: 3047-3054.
28. Eschbaumer M, Wackerlin R, Savini G, Zientara S, Sailleau C, et al. (2011) Contamination in bluetongue virus challenge experiments. Vaccine 29: 4299-4301.
29. Umeshappa CS, Singh KP, Pandey AB, Singh RP, Nanjundappa RH, (2010) Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep. Vaccine 28: 2522-2531.
30. French TJ, Marshall JJ, Roy P, (1990) Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol 64: 5695-5700.
31. Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K, (2007) Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods 140: 115-123.
32. Marshall JJ, Roy P, (1990) High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection. Virus Res 15: 189-195.
33. van der Walt NT, (1980) A haemagglutination and haemagglutination inhibition test for bluetongue virus. Onderstepoort J Vet Res 47: 113-117.